|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:adjuvant
|
gptkb:CpG_1018
aluminum hydroxide
|
|
gptkbp:administeredBy
|
gptkb:Eswatini
gptkb:Paraguay
gptkb:Taiwan
|
|
gptkbp:age
|
18 years and older
|
|
gptkbp:antigen
|
gptkb:SARS-CoV-2_spike_protein
|
|
gptkbp:approvedBy
|
2021-07-19
|
|
gptkbp:boosterRecommended
|
yes
|
|
gptkbp:brand
|
gptkb:Medigen_COVID-19_vaccine
|
|
gptkbp:clinicalTrialPhase
|
gptkb:Eswatini
gptkb:Paraguay
gptkb:Taiwan
Phase 3
|
|
gptkbp:countryOfOrigin
|
gptkb:Taiwan
|
|
gptkbp:developedBy
|
gptkb:Medigen_Vaccine_Biologics_Corporation
|
|
gptkbp:efficacyAgainstSevereDisease
|
high
|
|
gptkbp:emergencyServices
|
gptkb:Taiwan
|
|
gptkbp:form
|
intramuscular injection
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MVC-COV1901
|
|
gptkbp:intervalBetweenDoses
|
28 days
|
|
gptkbp:numberOfDoses
|
2
|
|
gptkbp:regulates
|
gptkb:Taiwan_Food_and_Drug_Administration
|
|
gptkbp:routeOfAdministration
|
intramuscular
|
|
gptkbp:safetyProfile
|
well tolerated
|
|
gptkbp:storage
|
2–8°C
|
|
gptkbp:target
|
gptkb:COVID-19
|
|
gptkbp:type
|
protein subunit vaccine
|
|
gptkbp:WHOStatus
|
not listed
|
|
gptkbp:bfsParent
|
gptkb:Medigen
|
|
gptkbp:bfsLayer
|
7
|